Format

Send to

Choose Destination
Brain Res Mol Brain Res. 2003 Aug 19;116(1-2):155-8.

Beta-secretase (BACE) and GSK-3 mRNA levels in Alzheimer's disease.

Author information

1
Quantuum, Departamento de Neurología, Rua das Brañas 7-bajo-D, Mera, La Coruña, Galicia 15177, Spain. pablo@quantuum.com

Abstract

Beta-secretase (BACE) and glycogen synthase kinase (GSK 3) are two enzymes thought to play a role in Alzheimer's disease. We extracted mRNA from 90 Alzheimer and 81 control brains. Levels of mRNA were quantified for BACE and GSK 3 with TaqMan real-time RT-PCR. We found no change in the Alzheimer's disease brains relative to controls for either the BACE or the GSK 3alpha mRNA levels.

PMID:
12941471
[Indexed for MEDLINE]

Supplemental Content

Full text links

Icon for Elsevier Science
Loading ...
Support Center